Mark Yarchoan, MD

Mark Yarchoan, MD

Articles by Mark Yarchoan, MD
Feasibility of Personalized Neoantigen Vaccines Plus Pembrolizumab for Advanced HCC
Mark Yarchoan, MDUnresectable HCC | May 15, 2024
Dr. Yarchoan details neoantigen-specific T cell responses assessed in the study.
Read More

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |